Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel

• SemBioSys Submits IND for Safflower-Produced Insulin to U.S. FDA
• SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
• Movetis' Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites
• Isotechnika Reports Final Results of the PROMISE Trial
• Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
• Isotechnika to Hold Conference Call to Discuss Positive PROMISE Trial
• Isotechnika Presents Positive Data From the Promise Trial of Voclosporin at the American Transplant Congress
• Tibotec Begins Enrollment in Europe for Phase III Trial of Telaprevir in HCV Patients who Failed Prior Treatment
• MabThera Filed in the EU for Treatment of Most Common Leukaemia in Adults
• Sanofi Aventis: New Real Life Studies Illustrate Greater A1C Lowering and Cost Benefit Observed With LANTUS(R) Over Detemir and NPH Insulin

2008 Dezember archive at Medizin News

PRNewswire) - - TSX symbol: SBS SemBioSys Genetics Inc. Sembiosys Eligible To Proceed With Phase I/ii Plant-produced Insulin Trial After Submission Of Ind

Sembiosys Eligible To Proceed With Phase I/ii Plant-produced Insulin ...

Sembiosys Eligible To Proceed With Phase I/ii Plant-produced Insulin Trial After Submission Of Ind PRNewswire) - - TSX symbol: SBS SemBioSys Genetics Inc.

Presseportal: SemBioSys, Genetics Inc - SemBioSys wählt ehemaligen ...

16.09.08 15:53 SemBioSys Eligible to Proceed With Phase I/II Plant-Produced Insulin Trial After Submission of IND IND for Safflower-Produced Insulin to

ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

SemBioSys Eligible to Proceed With Phase I/II Plant-Produced Insulin Trial After Submission of IND Regulatory Path for Plant-Produced Insulin After

Presseportal: SemBioSys, Genetics Inc

SemBioSys Eligible to Proceed With Phase I/II Plant-Produced Insulin Trial After Submission of IND Regulatory Path for Plant-Produced Insulin After